RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DE BONO J
Collezione ASL Torino 4

Items : 4

Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1. in European urology / Eur Urol. 2023 Apr;83(4):352-360. doi: 10.1016/j.eururo.2022.05.030. Epub 2022 Jun 22.

2023
ASL Torino 4
AOU San Luigi di Orbassano

Niyazov A; Arondekar B; Healy C; Bhattacharyya H; Gurney H; Higano CS; Maruzzo M; Renard V; Machiels JP; Scagliotti G; Stirling A; Mehra N; Barthélémy P; Dorff T; Fizazi K; de Bono J; Saad F;

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. in European urology / Eur Urol. 2022 Jul;82(1):6-11. doi: 10.1016/j.eururo.2022.02.010. Epub 2022 Feb 17.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Sydes M; Sweeney C; Suzuki H; Sternberg CN; Spratt D; Smith M; Soule H; Small E; Shore N; Skoneczna I; Scher HI; Sartor O; Pablo Sade J; Saad F; Ryan CJ; Rubin M; Reiter RE; Rathkopf D; Rabah DM; Pritchard CC; Parker C; Poon DMC; Padhani AR; O'Sullivan JM; Ost P; Ekeke Onyeanunam N; Oh WK; Murthy V; Morris MJ; et alii...

Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11]. in European urology / Eur Urol. 2022 Jul;82(1):e18-e19. doi: 10.1016/j.eururo.2022.04.004. Epub 2022 Apr 16.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Taplin ME; Sydes M; Sweeney C; Suzuki H; Spratt D; Sternberg CN; Soule H; Smith M; Small E; Skoneczna I; Shore N; Scher HI; Sartor O; Sade JP; Ryan CJ; Saad F; Reiter RE; Rubin M; Rathkopf D; Rabah DM; Pritchard CC; Parker C; Poon DMC; Padhani AR; O'Sullivan JM; Ost P; Ekeke ON; Murthy V; Oh WK; et alii...

TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with tumor DNA damage response alterations (DDRm)-Exploration of germline DDR alteration landscape and potential associations with antitumor activity in Journal of Clinical Oncology

2022
ASL Torino 4

Dorff TB; Fizazi K; Laird D; Barthélémy P; Delva R; Maruzzo M; Stirling A; MacHiels J-PH; Dumez H; Renard V; Hopkins J; Albacker LA; Chen H-C; Healy CG; Chelliserry J; Van Oort IM; Scagliotti GV; De Bono JS; Mehra N;